Meihua International Medical Technologies Co Ltd Statistics
Want to see MHUAF full AI Analyst Report?
Meihua International Medical Technologies Co Ltd (MHUAF) Stock Statistics & Valuation Metrics
Total Valuation
Meihua International Medical Technologies Co Ltd has a market cap or net worth of $4.93M. The enterprise value is -$373.79B.
- Market Cap
- $4.93M
- Enterprise Value
- -$373.79B
Share Statistics
Meihua International Medical Technologies Co Ltd has 857,914 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 857,914
- Owned by Insiders
- ―
- Owned by Institutions
- 0.02%
Financial Efficiency
Meihua International Medical Technologies Co Ltd’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.02%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 3.02%
- Return on Capital Employed (ROCE)
- 0.04
- Revenue Per Employee
- 127.14K
- Profits Per Employee
- 13.95K
- Employee Count
- 486
- Asset Turnover
- 0.30
- Inventory Turnover
- 25.11
Valuation Ratios
The current PE Ratio of Meihua International Medical Technologies Co Ltd is 0.40. Meihua International Medical Technologies Co Ltd’s PEG ratio is -0.01.
- PE Ratio
- 0.40
- PS Ratio
- 0.07
- PB Ratio
- 0.02
- Price to FCF
- 7.56
- Price to Operating Cash Flow
- 7.32
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Meihua International Medical Technologies Co Ltd had revenue of 61.79M and earned 6.78M in profits. Earnings per share was 18.04.
- Revenue
- 61.79M
- Gross Profit
- 18.99M
- Operating Income
- 8.28M
- Pretax Income
- 9.41M
- Net Income
- 6.78M
- EBITDA
- 8.83M
- Earnings Per Share (EPS)
- 18.04
Cash Flow
In the last 12 months, operating cash flow was 569.88K and capital expenditures -15,632, giving a free cash flow of 554.25K billion.
- Operating Cash Flow
- 569.88K
- Free Cash Flow
- 554.25K
- Free Cash Flow per Share
- 0.80
Dividends & Yields
Meihua International Medical Technologies Co Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 13.24%
- Earnings Yield
- 162.49%
Stock Price Statistics
- Beta
- 1.14
- 52-Week Price Change
- -73.94%
- 50-Day Moving Average
- 6.91
- 200-Day Moving Average
- 8.04
- Relative Strength Index (RSI)
- 15.09
- Average Volume (3m)
- 786
Important Dates
Meihua International Medical Technologies Co Ltd upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Apr 23, 2026
- Next Earnings Date
- Nov 16, 2026
- Ex-Dividend Date
- ―
Financial Position
Meihua International Medical Technologies Co Ltd as a current ratio of 8.42, with Debt / Equity ratio of 4.76%
- Current Ratio
- 8.42
- Quick Ratio
- 8.32
- Debt to Market Cap
- 11.66
- Net Debt to EBITDA
- -0.70
- Interest Coverage Ratio
- 34.30
Taxes
In the past 12 months, Meihua International Medical Technologies Co Ltd has paid 2.62M in taxes.
- Income Tax
- 2.62M
- Effective Tax Rate
- 0.28
Enterprise Valuation
Meihua International Medical Technologies Co Ltd EV to EBITDA ratio is -0.22, with an EV/FCF ratio of -3.57.
- EV to Sales
- -0.03
- EV to EBITDA
- -0.22
- EV to Free Cash Flow
- -3.57
- EV to Operating Cash Flow
- -3.47
Balance Sheet
Meihua International Medical Technologies Co Ltd has $15.15M in cash and marketable securities with $8.99M in debt, giving a net cash position of $6.17M billion.
- Cash & Marketable Securities
- $15.15M
- Total Debt
- $8.99M
- Net Cash
- $6.17M
- Net Cash Per Share
- $7.19
- Tangible Book Value Per Share
- $270.97
Margins
Gross margin is 30.88%, with operating margin of 13.41%, and net profit margin of 10.98%.
- Gross Margin
- 30.88%
- Operating Margin
- 13.41%
- Pretax Margin
- 15.22%
- Net Profit Margin
- 10.98%
- EBITDA Margin
- 14.30%
- EBIT Margin
- 13.41%
Analyst Forecast
The average price target for Meihua International Medical Technologies Co Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -36.24%
- EPS Growth Forecast
- -61.74%
Scores
- Smart Score
- ―
- AI Score
- 56

